类风湿关节炎缺血性与非缺血性心脏病的发病机制
本文为综述,旨在阐述类风湿关节炎(RA)心力衰竭的发病机制。文章强调缺血性与非缺血性心脏病的根本差异及其对RA心血管相关超额死亡率的意义,指出全身性炎症是RA心脏疾病的关键触发因素,并讨论传统与生物抗风湿药物及TNF-α与抗TNF-α治疗的作用。
要点
- 缺血性与非缺血性心脏病是RA心血管相关超额死亡的重要基础。
- RA患者常见无症状的心脏组织与冠状动脉改变。
- 全身性炎症是RA缺血性与非缺血性心脏病的关键触发因素。
核心结论
- 心血管疾病是RA中最主要的与死亡相关的合并症。
- 全身性炎症是RA中缺血性与非缺血性心脏病的关键触发因素。
- TNF-α与抗TNF-α治疗在RA缺血性与非缺血性心脏病发生与进展中的作用被讨论。
研究设计与样本
- 综述:检索范围未在摘要中报告,本文旨在描述RA心力衰竭的发病机制。
主要发现
- 临床数据显示心血管疾病是RA中与死亡率相关的主要合并症。
- RA诊断患者中常见无症状的心脏组织与冠状动脉改变。
- 传统与生物抗风湿药物对心脏病发生与进展存在影响。
临床怎么用
- 解读RA心脏合并症时需区分缺血性与非缺血性心脏病路径。
- 关注RA患者心脏组织与冠状动脉的无症状改变。
- 将全身性炎症负荷纳入RA心血管风险管理考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatoid arthritis (RA) is characterised by a chronic inflammatory condition of the joints, but the comorbidities of RA predominantly contribute to the reduced lifespan associated with this disease. Clinical data indicate that cardiovascular disease is the major comorbidity associated with mortality in RA. In this review, we aimed to describe the pathogenesis of heart failure in RA. First, we emphasised the fundamental differences between ischaemic and non-ischaemic heart diseases and referred to their relevance in excessive cardiovascular-dependent mortality in RA. Second, we highlighted aspects of asymptomatic changes in cardiac tissue and in coronary blood vessels that are commonly found in patients with diagnosed RA. Third, we focused on high-grade systemic inflammation as a key trigger of ischaemic and non-ischaemic heart diseases in RA, and described the implication of conventional and biologic antirheumatic medications on the development and progression of heart disease. In particular, we discussed the roles of tumour necrosis factor-alpha (TNF-α) and anti-TNF-α therapies on the development and progression of ischaemic and non-ischaemic heart diseases in RA.
引用
- Błyszczuk P, Szekanecz Z. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis. RMD Open. 2020. PMID: 31958278. doi:10.1136/rmdopen-2019-001032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。